Free Cash Flow Build Up

Acorda Therapeutics Inc

Acorda Therapeutics Inc (ACOR)

$6.7
0.33 (+5.18%)
Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
Revenue 336.43401.48492.66519.60588.29471.43192.41186.53180.84175.32169.97164.78
EBITDA 38.0354.9660.754.44127.68108.50-82.2510.7010.3710.069.759.45
EBIT 31.0346.4945.74-17.14104.4497.02-116.821.171.141.101.071.04
Tax Rate 43.04%36.91%42.91%18.10%11.33%-64.92%0.47%12.55%12.55%12.55%12.55%12.55%
EBIAT 17.6829.3326.11-14.0492.61160.01-116.281.031.000.970.940.91
Depreciation 7.008.4715.0121.5823.2311.4834.579.539.238.958.688.41
Accounts Receivable --1.430.74-20.77-29.1657.971.355.060.520.500.490.47
Inventories --0.66-9.64-6.665.638.493.7910.350.450.440.430.41
Accounts Payable -2.31-3.2212.841.1618.29-22.53-13.69-0.40-0.39-0.38-0.37
Capital Expenditure -14.66-483.93-7.07-273.54-14.38-33.91-90.43-62.78-60.87-59.01-57.21-55.46
UFCF 10.01-445.9221.95-280.5979.11222.33-189.52-50.52-50.07-48.54-47.06-45.62
WACC
PV UFCF -46.24-41.94-37.21-33.02-29.30
SUM PV UFCF -187.71